Ticker League

EBITDA for Labcorp Holdings (LH)

Latest filings through · Reported

Metric

TTM

$2.06B

YoY change

+11.1%

5Y CAGR

-9.1%

Peak year (2021)

$3.68B

EBITDA history chart for Labcorp Holdings (LH) from 1988 to 2025

Latest: $2.01B

EBITDA growth chart for Labcorp Holdings (LH) from 1988 to 2025

Latest: +11.1%

EBITDA history table for Labcorp Holdings (LH) from 1988 to 2025

  • 2025$2.01B+11.1%
  • 2024$1.81B+34.2%
  • 2023$1.35B-31.0%
  • 2022$1.95B-46.8%
  • 2021$3.68B+13.1%
  • 2020$3.25B+53.6%
  • 2019$2.12B+2.5%
  • 2018$2.06B+11.9%
  • 2017$1.85B+2.0%
  • 2016$1.81B+14.8%
  • 2015$1.58B+34.1%
  • 2014$1.18B-5.1%
  • 2013$1.24B-1.7%
  • 2012$1.26B+6.7%
  • 2011$1.18B-0.7%
  • 2010$1.19B+4.2%
  • 2009$1.14B+10.1%
  • 2008$1.04B+4.6%
  • 2007$990.40M+16.1%
  • 2006$853.10M+8.7%
  • 2005$784.80M-0.7%
  • 2004$790.20M+18.2%
  • 2003$668.40M+20.6%
  • 2002$554.30M+17.5%
  • 2001$471.60M+38.8%
  • 2000$339.70M+45.0%
  • 1999$234.20M+10.6%
  • 1998$211.80M+1110.3%
  • 1997$17.50M-90.6%
  • 1996$186.70M+33.7%
  • 1995$139.60M-9.5%
  • 1994$154.30M-29.1%
  • 1993$217.70M-4.1%
  • 1992$227.00M+16.1%
  • 1991$195.50M+23.1%
  • 1990$158.80M+25.9%
  • 1989$126.10M-59.8%
  • 1988$313.90M—

EBITDA values are taken from Labcorp Holdings's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Labcorp Holdings (LH)

According to Labcorp Holdings's latest reported financial statements, the company's current EBITDA (TTM) is $2.06B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Labcorp Holdings (LH) EBITDA is $2.01B – grew 11.1% year-over-year.

Labcorp Holdings EBITDA has grown for 2 consecutive years, with a -9.1% compound annual growth rate over 2020–2025 (5 years).

Labcorp Holdings EBITDA plunged from $3.68B in 2021 to $2.01B in 2025, a 45.3% drawdown.

$3.68B stands as the all-time-high annual EBITDA, posted in 2021, against a low of $17.50M during 1997.

Labcorp Holdings EBITDA by Year

Labcorp Holdings EBITDA 2025: $2.01B

2025's EBITDA for Labcorp Holdings came in at $2.01B, grew 11.1% from 2024.

Labcorp Holdings EBITDA 2024: $1.81B

Labcorp Holdings posted EBITDA of $1.81B in 2024, surged 34.2% from 2023.

Labcorp Holdings EBITDA 2023: $1.35B

In 2023, Labcorp Holdings reported EBITDA of $1.35B, plunged 31.0% below 2022.

Labcorp Holdings EBITDA 2022: $1.95B

Labcorp Holdings EBITDA in 2022 was $1.95B, plunged 46.8% below 2021.

Labcorp Holdings EBITDA 2021: $3.68B

Labcorp Holdings EBITDA in 2021 was $3.68B.

See more financial history for Labcorp Holdings (LH).

Sector peers by EBITDA

Healthcare peers of Labcorp Holdings (LH), ranked by their latest EBITDA

Frequently asked questions

Labcorp Holdings (LH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview